All In Biotech

Drug Trial Radar · NCT07522073

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 588 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

588

Planned (sponsor's estimate)

Start

Apr 9, 2026

Primary completion

Sep 15, 2028

Study completion Mar 19, 2029

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
Collaborators
Qiagen Manchester Ltd
First posted
Apr 13, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal adenocarcinoma (PDAC).

Conditions

  • Solid Tumors

Interventions

  • INCB161734Drug

    Oral; tablet

  • PlaceboDrug

    Oral; tablet

  • Investigator's choice of chemotherapyDrug

    The investigator will select the chemotherapy in accordance with the protocol-defined requirements. The possible choices as defined by the protocol:

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: Up to approximately 3 years
  2. Progression-free survival (PFS) by BICRTime frame: Up to approximately 2 years
  3. Objective Response by BICRTime frame: Up to approximately 2 years

Locations

230 sites in 22 countries. Site status is shown where the registry gives one.

  • Investigative Site US058

    Birmingham, Alabama · Recruiting

  • Investigative Site US016

    Anchorage, Alaska · Recruiting

  • Investigative Site US026

    Chandler, Arizona · Recruiting

  • Investigative Site US045

    Tucson, Arizona · Recruiting

  • Investigative Site US051

    Duarte, California · Recruiting

  • Investigative Site US085

    Fullerton, California · Not yet recruiting

  • Investigative Site US054

    La Jolla, California · Not yet recruiting

  • Investigative Site US086

    Long Beach, California · Not yet recruiting

  • Investigative Site US027

    Los Angeles, California · Recruiting

  • Investigative Site US036

    Los Angeles, California · Recruiting

  • Investigative Site US048

    Los Angeles, California · Recruiting

  • Investigative Site US049

    Orange, California · Recruiting

  • Investigative Site US034

    San Francisco, California · Recruiting

  • Investigative Site US001

    Santa Monica, California · Recruiting

  • Investigative Site US071

    Denver, Colorado · Recruiting

  • Investigative Site US013

    Washington D.C., District of Columbia · Recruiting

  • Investigative Site US046

    Washington D.C., District of Columbia · Not yet recruiting

  • Investigative Site US072

    Fort Myers, Florida · Recruiting

  • Investigative Site US083

    Jacksonville, Florida · Not yet recruiting

  • Investigative Site US075

    Miami, Florida · Recruiting

  • Investigative Site US074

    St. Petersburg, Florida · Recruiting

  • Investigative Site US073

    West Palm Beach, Florida · Recruiting

  • Investigative Site US023

    Atlanta, Georgia · Recruiting

  • Investigative Site US079

    Chicago, Illinois · Not yet recruiting

  • Investigative Site US030

    Evanston, Illinois · Recruiting

  • Investigative Site US005

    Naperville, Illinois · Recruiting

  • Investigative Site US009

    Springfield, Illinois · Recruiting

  • Investigative Site US021

    Indianapolis, Indiana · Not yet recruiting

  • Investigative Site US007

    New Orleans, Louisiana · Recruiting

  • Investigative Site US022

    Boston, Massachusetts · Recruiting

  • Investigative Site US006

    Ann Arbor, Michigan · Recruiting

  • Investigative Site US010

    Detroit, Michigan · Recruiting

  • Investigative Site US078

    Grand Rapids, Michigan · Recruiting

  • Investigative Site US012

    Ypsilanti, Michigan · Not yet recruiting

  • Investigative Site US066

    Maple Grove, Minnesota · Recruiting

  • Investigative Site US047

    Hattiesburg, Mississippi · Not yet recruiting

  • Investigative Site US084

    Reno, Nevada · Not yet recruiting

  • Investigative Site US077

    Hackensack, New Jersey · Recruiting

  • Investigative Site US017

    Morristown, New Jersey · Recruiting

  • Investigative Site US059

    Lake Success, New York · Recruiting

Showing 40 of 230 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.